Skip to content

Compounds · Skin & hair · Anti-inflammatory peptide for skin conditions

KPV

On NovaEvumFull protocol

α-MSH(11-13), Alpha-MSH(11-13), Ac-Lys-Pro-Val

C-terminal tripeptide fragment of alpha-MSH, studied for anti-inflammatory and antimicrobial effects. Investigated for colitis, psoriasis, and wound healing without the immunosuppressive downsides of steroids.

0.2–0.5 mg daily

Research score 60/100. Reference only, not a prescription.

  • Anti-inflammatory
  • Skin Health
  • Wound Healing
  • Inflammation Resolution
US status
Research Chemical
Approval
Research Chemical Only
Evidence
Preclinical studies and limited human experimental use (topical/oral).
Research score
60 / 100
Indication
Research Only - No Medical Indication
Origin
USA
Source category
Skin & Dermatology
Status group
Research chemical

Mechanism

Acts independently of melanocortin receptors to block pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and NF-κB signaling in keratinocytes and immune cells, without triggering the pigmentation effects of its parent hormone α-MSH.

Safety file

Good safety profile in available studies; mild skin irritation topically and mild GI upset orally, but no long-term human data.

  • Well-tolerated with minimal side effects

Reconstitution

Concentration by vial size and water volume
Vial2 mL water3 mL water
10 mg5 mg/mL3.33 mg/mL
  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.

Full mixing method

Protocol

Route: Subcutaneous

Standard protocol (subcutaneous)

  • 0.25 mg (250 mcg) once daily to start, up to 0.5 mg
  • At a 2 mL fill (5 mg/mL), 0.25 mg is 5 units and 0.5 mg is 10 units
  • For gut-focused use it is often run daily through an active flare

Dosing detail

  • Common daily dose is around 0.2 mg to 0.5 mg, starting at 0.25 mg.
  • Once daily subcutaneous is the usual approach.
  • Often used in shorter courses during an active inflammatory or gut issue rather than continuously.
  • Community dosing data for KPV is thinner than for BPC-157 or TB-500, so start conservative and assess.

Duration

  • Typically a 2 to 4 week course around an inflammatory issue, then stop or taper. Repeat as needed around flares.

Notes

  • An anti-inflammatory tripeptide, popular for gut inflammation and skin issues.
  • Generally well tolerated.
  • Rotate sites.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.

Storage rules and when to discard

NovaEvum vial

Worksheet

2 mL bacteriostatic water into 10 mg gives 5 mg/mL, 50 mcg/unit. A 250 mcg amount is 5 units.

Catalog fill
10 mg
Typical water
2 mL
Route
Subcutaneous
Cycle
2–4 weeks.
StepAmountFrequencyNotes
Common range200–250 mcgOnce daily—
Upper cited range500 mcgOnce daily—
  • Also a component of KLOW. Do not stack a full KPV vial on top of KLOW without accounting for the overlap.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.